Open-mkt buys · 90d
$10.08M
4 trades · 3 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$10.08M
Insiders on file
10
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Westlake BioPartners GP I, LLC | 10% Owner | 14 | $0 | $0 | 2026-08-10 |
| Foresite Capital Fund VI LP | 10% Owner | 15 | $2.52M | $0 | 2026-08-10 |
| 5AM Partners VI, LLC | 10% Owner | 6 | $0 | $0 | 2026-08-10 |
| Foresite Capital Management V, LLC | 10% Owner | 15 | $2.52M | $0 | 2026-08-10 |
| 5AM Ventures VI, L.P. | 10% Owner | 6 | $0 | $0 | 2026-08-10 |
| Westlake BioPartners Fund I, L.P. | 10% Owner | 14 | $0 | $0 | 2026-08-10 |
| Tananbaum James B. | Director, 10% Owner | 30 | $5.04M | $0 | 2026-08-10 |
| SEIDENBERG BETH C | Director, 10% Owner | 28 | $0 | $0 | 2026-08-10 |
| Sanofi | 10% Owner | 8 | $0 | $0 | 2026-08-10 |
| SMITH TODD N | Director | 2 | $0 | $0 | 2026-08-06 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 165,519 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 2,066,857 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,484,401 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,547,842 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,027,635 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,464,072 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 938,979 | — | $0 | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 195,776 | — | $0 | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 0 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 195,776 | — | $0 | 0 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 0 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 0 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 0 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 0 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 938,979 | — | $0 | 0 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 165,519 | — | $0 | 0 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 2,066,857 | — | $0 | 0 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 1,484,401 | — | $0 | 0 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 3,464,072 | — | $0 | 0 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 1,027,635 | — | $0 | 0 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 3,547,842 | — | $0 | 0 | SEC↗ |
| Sanofi | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 494,800 | — | $0 | 0 | SEC↗ |
| Sanofi | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 177,978 | — | $0 | 0 | SEC↗ |
| 5AM Partners VI, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 3,152,305 | — | $0 | 0 | SEC↗ |
| 5AM Partners VI, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,823,238 | — | $0 | 0 | SEC↗ |
| 5AM Partners VI, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 866,018 | — | $0 | 0 | SEC↗ |
| 5AM Partners VI, LLC | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,484,401 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,547,842 | — | $0 | 4,916,374 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 938,979 | — | $0 | 1,368,532 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 1,027,635 | — | $0 | 5,944,009 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,464,072 | — | $0 | 3,510,927 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 1,484,401 | — | $0 | 4,995,328 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 165,519 | — | $0 | 5,160,847 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 2,066,857 | — | $0 | 2,094,813 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 3,562,984 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 3,414,544 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 1,125,823 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 1,868,024 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | P Buy | 2026-08-10 | 2026-08-10 | 140,000 | $18.00 | $2.52M | 2,008,024 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 195,776 | — | $0 | 2,203,800 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 3,414,544 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 3,562,984 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 1,125,823 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 1,868,024 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | P Buy | 2026-08-10 | 2026-08-10 | 140,000 | $18.00 | $2.52M | 2,008,024 | SEC↗ |
| Foresite Capital Fund VI LP | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 195,776 | — | $0 | 2,203,800 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 1,484,401 | — | $0 | 4,995,328 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 3,464,072 | — | $0 | 3,510,927 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 1,027,635 | — | $0 | 5,944,009 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 165,519 | — | $0 | 5,160,847 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 2,066,857 | — | $0 | 2,094,813 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 3,547,842 | — | $0 | 4,916,374 | SEC↗ |
| Westlake BioPartners GP I, LLC | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 938,979 | — | $0 | 1,368,532 | SEC↗ |
| Sanofi | 10% Owner | C Conversion | 2026-08-10 | 2026-08-12 | 177,978 | — | $0 | 672,788 | SEC↗ |
| Sanofi | 10% Owner | C Conversion | 2026-08-10 | 2026-08-12 | 494,800 | — | $0 | 494,800 | SEC↗ |
| 5AM Partners VI, LLC | 10% Owner | C Conversion | 2026-08-10 | 2026-08-12 | 4,975,543 | — | $0 | 4,975,543 | SEC↗ |
| 5AM Partners VI, LLC | 10% Owner | C Conversion | 2026-08-10 | 2026-08-12 | 2,350,419 | — | $0 | 2,350,419 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 195,776 | — | — | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 296,880 | — | — | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | — | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 742,201 | — | — | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,125,823 | — | — | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 445,320 | — | — | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | — | 0 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 296,880 | — | — | 3,414,544 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | — | 3,117,664 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 195,776 | — | — | 2,203,800 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | P Buy | 2026-08-10 | 2026-08-10 | 140,000 | $18.00 | $2.52M | 2,008,024 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 742,201 | — | — | 1,868,024 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 1,125,823 | — | — | 1,125,823 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 445,320 | — | — | 3,562,984 | SEC↗ |
| Tananbaum James B. | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | — | 3,117,664 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 165,519 | — | — | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 2,066,857 | — | — | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,484,401 | — | — | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,464,072 | — | — | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,027,635 | — | — | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,547,842 | — | — | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 938,979 | — | — | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 2,066,857 | — | — | 2,094,813 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 165,519 | — | — | 5,160,847 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 1,484,401 | — | — | 4,995,328 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,464,072 | — | — | 3,510,927 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 1,027,635 | — | — | 5,944,009 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,547,842 | — | — | 4,916,374 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 938,979 | — | — | 1,368,532 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 195,776 | — | — | 0 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 0 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 0 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 0 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 0 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 3,414,544 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 195,776 | — | — | 2,203,800 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | P Buy | 2026-08-10 | 2026-08-10 | 140,000 | $18.00 | $2.52M | 2,008,024 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 1,868,024 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 1,125,823 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 3,562,984 | SEC↗ |
| Foresite Capital Management V, | 10% Owner | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 165,519 | — | — | 0 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 2,066,857 | — | — | 0 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 1,484,401 | — | — | 0 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 3,464,072 | — | — | 0 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 1,027,635 | — | — | 0 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 3,547,842 | — | — | 0 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-11 | 938,979 | — | — | 0 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 2,066,857 | — | — | 2,094,813 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 165,519 | — | — | 5,160,847 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 1,484,401 | — | — | 4,995,328 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 3,464,072 | — | — | 3,510,927 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 1,027,635 | — | — | 5,944,009 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 3,547,842 | — | — | 4,916,374 | SEC↗ |
| Westlake BioPartners Fund I, L | 10% Owner | C Conversion | 2026-08-10 | 2026-08-11 | 938,979 | — | — | 1,368,532 | SEC↗ |
| Sanofi | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 177,978 | — | — | 0 | SEC↗ |
| Sanofi | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 494,800 | — | — | 0 | SEC↗ |
| Sanofi | 10% Owner | C Conversion | 2026-08-10 | 2026-08-12 | 177,978 | — | — | 672,788 | SEC↗ |
| Sanofi | 10% Owner | C Conversion | 2026-08-10 | 2026-08-12 | 494,800 | — | — | 494,800 | SEC↗ |
| 5AM Ventures VI, L.P. | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,484,401 | — | $0 | 0 | SEC↗ |
| 5AM Ventures VI, L.P. | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 866,018 | — | $0 | 0 | SEC↗ |
| 5AM Ventures VI, L.P. | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,823,238 | — | $0 | 0 | SEC↗ |
| 5AM Ventures VI, L.P. | 10% Owner | C Conversion deriv | 2026-08-10 | 2026-08-12 | 3,152,305 | — | $0 | 0 | SEC↗ |
| 5AM Ventures VI, L.P. | 10% Owner | C Conversion | 2026-08-10 | 2026-08-12 | 2,350,419 | — | — | 2,350,419 | SEC↗ |
| 5AM Ventures VI, L.P. | 10% Owner | C Conversion | 2026-08-10 | 2026-08-12 | 4,975,543 | — | — | 4,975,543 | SEC↗ |
| SMITH TODD N | Director | A Award deriv | 2026-08-06 | 2026-08-10 | 105,542 | — | $0 | 105,542 | SEC↗ |
| SMITH TODD N | Director | A Award deriv | 2026-08-06 | 2026-08-10 | 105,542 | — | $0 | 105,542 | SEC↗ |